Suga Hirotaka, Shiraishi Tomohiro, Takushima Akihiko
From the Department of Plastic Surgery, Kyorin University School of Medicine, Tokyo, Japan.
Ann Plast Surg. 2020 Sep;85(3):229-232. doi: 10.1097/SAP.0000000000002238.
Breast scars after breast reconstruction can be hypertrophic and/or hyperpigmented, especially in Asian patients, whose skin is thicker and has increased melanin. Few studies have focused on breast scars after breast reconstruction, and the risk factors for an abnormal breast scar remain unknown.
We examined 257 Asian patients who underwent an immediate 2-stage unilateral implant-based breast reconstruction. Vascularity, hypertrophy, and hyperpigmentation of the patients' breast scars were assessed at 1 year postoperatively. Risk factors for an abnormal scar were analyzed statistically. Analyzed patient factors included age, body mass index, incision site (frontal or lateral), breast size (the weight of the resected specimen), skin necrosis at the initial operation (expander placement), and adjuvant therapy.
At 1 year postoperatively, 161 patients (63%) showed normal vascularity, 77 patients (30%) showed mild vascularity, 18 patients (7%) showed moderate vascularity, and 1 patient (0.4%) showed severe vascularity. No patient factors were correlated with vascularity. Thirty-two patients (12%) showed hypertrophy, and the rate of hypertrophy was significantly higher in the patients with a lateral incision (n = 59) compared with those with a frontal incision (n = 198) (28.8% vs 7.6%, P < 0.01). Even in the frontal incision group, a lateral part of the frontal scar was likely to be hypertrophic. Forty-six patients (18%) showed hyperpigmentation, and the rate of hyperpigmentation was significantly higher in the patients with skin necrosis (n = 47) at the initial operation than those without skin necrosis (n = 210) (57.4% vs 9.0%, P < 0.01). Large breast was also a risk factor for hyperpigmentation due to its higher frequency of skin necrosis.
In Asian patients who undergo breast reconstruction, the use of a lateral incision is a risk factor for hypertrophy, and skin necrosis at the initial operation is a risk factor for hyperpigmentation at the breast scar.
乳房重建术后的乳房瘢痕可能会增生和/或色素沉着,尤其是在亚洲患者中,他们的皮肤更厚且黑色素增加。很少有研究关注乳房重建术后的乳房瘢痕,异常乳房瘢痕的危险因素仍然未知。
我们检查了257例接受一期双侧即刻乳房重建术的亚洲患者。在术后1年评估患者乳房瘢痕的血管生成、增生和色素沉着情况。对异常瘢痕的危险因素进行统计学分析。分析的患者因素包括年龄、体重指数、切口部位(正面或侧面)、乳房大小(切除标本的重量)、初次手术(置入扩张器)时的皮肤坏死情况以及辅助治疗。
术后1年,161例患者(63%)显示正常血管生成,77例患者(30%)显示轻度血管生成,18例患者(7%)显示中度血管生成,1例患者(0.4%)显示重度血管生成。没有患者因素与血管生成相关。32例患者(12%)出现增生,侧面切口患者(n = 59)的增生率显著高于正面切口患者(n = 198)(28.8%对7.6%,P < 0.01)。即使在正面切口组中,正面瘢痕的外侧部分也容易增生。46例患者(18%)出现色素沉着,初次手术时有皮肤坏死的患者(n = 47)的色素沉着率显著高于无皮肤坏死的患者(n = 210)(57.4%对9.0%,P < 0.01)。乳房较大也是色素沉着的危险因素,因为其皮肤坏死的发生率更高。
在接受乳房重建的亚洲患者中,采用侧面切口是增生的危险因素,初次手术时的皮肤坏死是乳房瘢痕色素沉着的危险因素。